Gujarat Themis Sets Record Date for Dividend on Sept 23, 2026
Gujarat Themis Biosyn sets Sept 23, 2026 as record date for dividend. Dividend approval depends on members' nod at AGM on Sept 30, 2026. Source: ScoutQuest
Stock news timeline · GUJTHEM
Guj Themis Biosyn
News timeline · Last 30 days
23 Aug 2026 – 21 Sep 2026 · Times in IST
- Timeline updates
- 16
- Bullish
- 6
- Neutral
- 9
- Bearish
- 1
- Active days
- 10
News timeline
Showing 16 of 16 updates · Newest first
No matching updates
Change the keyword or sentiment above, then click Apply.
Friday, 18 Sep 20264 updates
Gujarat Themis Buys MBJ for JPY 21.5B in Debt-Equity Deal
Gujarat Themis Biosyn completed the acquisition of MicroBiopharm Japan Co. for JPY 21.5B, funded via debt-equity mix. MBJ operates 3 GMP-compliant plants and reported FY26 revenue of JPY 9.5B, with 40% revenue from outside Japan. Source: Business Standard
Gujarat Themis Biosyn Acquires MicrobioPharm Japan to Boost Global Reach
Gujarat Themis Biosyn acquires MicrobioPharm Japan to enhance fermentation skills. The purchase aims to expand product range and strengthen global presence. Source: Livesquawk
Gujarat Themis Biosyn: Company Finalizes Purchase Of Japan-Based Microbiopharm Japan Co., Ltd. To Enhance Fermentation Skills, Product Range, And Global Presence.
Wednesday, 16 Sep 20261 update
Gujarat Themis Raises ₹585 Cr via NCDs for Expansion
Gujarat Themis Biosyn allotted NCDs worth INR 585 crores for private placement to fund acquisitions and corporate purposes. The NCDs have tenures of 60 and 18 months, with interest rates of 10% and 17.75% p.a., secured on company assets. Source: BSE
Thursday, 10 Sep 20263 updates
Guj Themis OKs ₹585 Cr NCDs; Q1 Income Up 22% YoY
Gujarat Themis Biosyn approves raising ₹585 crore via NCDs on private placement. Q1 FY27 results: Income up 22% YoY to ₹43.79 crore; EBITDA margin rises to 47.5%. Source: CNBC TV 18
Gujarat Themis OKs ₹585 Cr NCD Issue for Business Expansion
Gujarat Themis Biosyn approved to issue NCDs worth ₹5.85B privately. This move aims to raise funds for the company's business needs. Source: Livesquawk
Gujarat Themis Biosyn: Gets Approval To Issue NCDs Worth Up To 5.85 Billion Rupees Privately.
Monday, 07 Sep 20262 updates
Gujarat Themis Biosyn: Board Will Review Fundraising Through Non-Convertible Debentures On September 10.
Gujarat Themis to Raise Funds via NCDs; Board Meet on Sep 10, 2026
Gujarat Themis Biosyn plans to raise funds via Non-Convertible Debentures by private placement. Board meeting set for 10th Sep 2026; trading window closed for designated persons. Source: BSE
Wednesday, 02 Sep 20261 update
Gujarat Themis Promoters' Stake Dips to 59.3% After QIP Allotment
Promoters of Gujarat Themis Biosyn Ltd reported a passive reduction in shareholding to 59.3%. This change follows a QIP allotment of 2.1 crore shares to non-promoters on 28.08.2026. Source: BSE
Tuesday, 01 Sep 20261 update
Gujarat Themis Biosyn: Board Approves 82.11 Lakh Shares Issuance at ₹408 Each, Totaling ₹335 Crore
Saturday, 29 Aug 20261 update
Gujarat Themis Biosyn: Receives Approval For Allotment Of 2.12 Crore Shares To QIBs At ₹354 Each, Raising Total Of ₹750 Crore Through QIP.
Friday, 28 Aug 20261 update
Gujarat Themis Biosyn: Allocates 2.12 Crore Equity Shares at ₹354 Each, Totaling ₹75 Crore.
Wednesday, 26 Aug 20261 update
Gujarat Themis Jumps 6% on QIP Nod; Q1 Profit Up 22% YoY
Gujarat Themis Biosyn gains 6% after QIP approval, aims to raise funds at ₹372.57/share. Q1 FY27 profit rises 22% YoY to ₹11.07 cr; EPS increases to ₹1.02; shares up 36% in 6 months. Source: CNBC TV 18
Sunday, 23 Aug 20261 update
Gujarat Themis Updates Share Pricing Rules in Articles
Gujarat Themis Biosyn Ltd amends Articles of Association via shareholder approval on 22 Aug 2026. Article 13(1)(c) revised to simplify share pricing, removing valuer-dependent conditions. Source: BSE